Renaissance Technologies’s TriSalus Life Sciences TLSI Stock Holding History

Renaissance Technologies’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-30,900	Closed	-$124K	–	3608
2026 Q1	$124K	Buy	+30,900	New	+$151K	﹤0.01%	2999
2025 Q2	–	Sell	-20,200	Closed	-$112K	–	3900
2025 Q1	$112K	Buy	20,200 +6,800	+51%	+$36.2K	﹤0.01%	3179
2024 Q4	$67.1K	Buy	+13,400	New	+$56.6K	﹤0.01%	3345

Other funds holding TLSI

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Renaissance Technologies's TLSI Position: Q2 2026 in Review

Renaissance Technologies sold out of TriSalus Life Sciences (TLSI) in Q2 2026, closing a stake of 30,900 shares — an estimated $124K sold.

Renaissance Technologies first reported a position in TLSI in Q4 2024 and held it in 3 quarters. The position peaked at $124K in Q1 2026. 79 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

Renaissance Technologies reported no remaining TriSalus Life Sciences position as of Q2 2026 after selling out during the quarter.
Renaissance Technologies sold 30,900 TriSalus Life Sciences shares in Q2 2026, an estimated $124K.
Renaissance Technologies first reported a position in TriSalus Life Sciences in Q4 2024 and held it in 3 quarters.
Renaissance Technologies's TriSalus Life Sciences position peaked at $124K in Q1 2026.
79 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.